Shurui Wu
Papers
1
Total Citations
2
H-Index
1
About
Dr. Shurui Wu is a pioneering hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly through robotic-assisted approaches. Her most impactful work addresses a critical gap in oncologic surgery: the feasibility and safety of robotic liver resection for huge hepatocellular carcinoma (HCC) measuring 10 cm or larger—a patient population often deemed high-risk for minimally invasive procedures. In a landmark 2024 study, Dr. Wu conducted a propensity score-matched, single-surgeon analysis of 337 patients, demonstrating that robotic resection for these massive tumors is not only feasible but offers comparable safety and oncologic outcomes to traditional open surgery. This work challenges long-standing surgical dogma and expands treatment options for patients with advanced HCC. While her citation count is still building—with this key paper accruing 2 citations to date—her contributions are already shaping clinical protocols in high-volume liver surgery centers. Dr. Wu’s dedication to refining robotic techniques and generating robust evidence for their broader application marks her as an emerging leader in surgical oncology, with her findings poised to influence future guidelines for managing complex liver malignancies.
Research Focus
Key Achievements
Top Papers
- 1